These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7026314)

  • 1. Pathological and therapeutic implications of the cellular and humoral responses to parathyrin.
    Parsons JA; Meunier P; Podbesek R; Reeve J; Stevenson RW
    Biochem Soc Trans; 1981 Oct; 9(5):383-6. PubMed ID: 7026314
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
    Reeve J; Arlot M; Bernat M; Charhon S; Edouard C; Slovik D; Vismans FJ; Meunier PJ
    Metab Bone Dis Relat Res; 1981; 3(1):23-30. PubMed ID: 7266363
    [No Abstract]   [Full Text] [Related]  

  • 3. Intestinal absorption of calcium in greyhounds: the response to intermittent and continuous administration of human synthetic parathyroid hormone fragment 1-34 (hPTH 1-34).
    Podbesek RD; Mawer EB; Zanelli GD; Parsons JA; Reeve J
    Clin Sci (Lond); 1984 Dec; 67(6):591-9. PubMed ID: 6548427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of parathyroid hormone on bone metabolism may be regulated by endogenously synthesized prostaglandin E2.
    Yang CY; Gonnerman WA; Polgar PR
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():435-8. PubMed ID: 2526513
    [No Abstract]   [Full Text] [Related]  

  • 5. Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
    Reeve J; Arlot M; Price TR; Edouard C; Hesp R; Hulme P; Ashby JP; Zanelli JM; Green JR; Tellez M
    Eur J Clin Invest; 1987 Oct; 17(5):421-8. PubMed ID: 3121346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anabolic activity of parathyroid hormone: a new therapeutic perspective in primary osteoporosis].
    Fiore CE; Tamburino G
    Ann Ital Med Int; 1987; 2(4):321-6. PubMed ID: 3079455
    [No Abstract]   [Full Text] [Related]  

  • 7. Extraction of parathyroid hormone and release of adenosine 3',5'-monophosphate by isolated perfused bones obtained from dogs with acute uremia.
    Olgaard K; Schwartz J; Finco D; Arbelaez M; Korkor A; Martin K; Klahr S; Slatopolsky E
    Endocrinology; 1982 Nov; 111(5):1678-82. PubMed ID: 6290194
    [No Abstract]   [Full Text] [Related]  

  • 8. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.
    Slovik DM; Rosenthal DI; Doppelt SH; Potts JT; Daly MA; Campbell JA; Neer RM
    J Bone Miner Res; 1986 Aug; 1(4):377-81. PubMed ID: 3503551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of osteoporosis in men.
    Orwoll ES
    Calcif Tissue Int; 2004 Aug; 75(2):114-9. PubMed ID: 15383924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recombinant human parathyroid hormone--new perspectives for anabolic therapy of osteoporosis].
    Miazgowski T; Stefański A
    Pol Arch Med Wewn; 2004 Oct; 112(4):1249-54. PubMed ID: 15773439
    [No Abstract]   [Full Text] [Related]  

  • 11. The anabolic effects of parathyroid hormone.
    Rubin MR; Cosman F; Lindsay R; Bilezikian JP
    Osteoporos Int; 2002; 13(4):267-77. PubMed ID: 12030541
    [No Abstract]   [Full Text] [Related]  

  • 12. The turnover time of calcium in the exchangeable pools of bone in man and the long-term effect of a parathyroid hormone fragment.
    Reeve J
    Clin Endocrinol (Oxf); 1978 Jun; 8(6):445-55. PubMed ID: 668151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.
    Slovik DM; Neer RM; Potts JT
    J Clin Invest; 1981 Nov; 68(5):1261-71. PubMed ID: 7298851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired skeletal response to parathyroid hormone in uremia: the role of phosphorus.
    Olgaard K; Schwartz J; Arbelaez M; Slatopolsky E
    Contrib Nephrol; 1985; 49():32-7. PubMed ID: 2420528
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant parathyroid hormone in the management of osteoporosis.
    Compston J
    Calcif Tissue Int; 2005 Aug; 77(2):65-71. PubMed ID: 16059774
    [No Abstract]   [Full Text] [Related]  

  • 16. Priliminary trial of low doses of human parathyroid hormone 1-34 peptide in treatment of osteoporosis.
    Reeve J; Tregear GW; Parsons JA
    Calcif Tissue Res; 1976 Aug; 21 Suppl():469-77. PubMed ID: 782668
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of osteoporosis: implications for treatment.
    Heaney RP
    Tex Med; 1974 Dec; 70(12):37-45. PubMed ID: 4610881
    [No Abstract]   [Full Text] [Related]  

  • 18. Parathyroid hormone as a therapeutic agent.
    Mitlak BH
    Curr Opin Pharmacol; 2002 Dec; 2(6):694-9. PubMed ID: 12482733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of osteoanabolic therapy: a decade of experience.
    Cipriani C; Irani D; Bilezikian JP
    J Bone Miner Res; 2012 Dec; 27(12):2419-28. PubMed ID: 23165426
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of PTH (1-34) on bone structure and strength in ovariectomized monkeys.
    Turner CH; Burr DB; Hock JM; Brommage R; Sato M
    Adv Exp Med Biol; 2001; 496():165-79. PubMed ID: 11783618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.